The use of i. v. bisphosphonate in pregnancy-associated osteoporosis - Case study

Objective: Diagnosis of pregnancy-associated osteoporosis is often delayed and therapeutic interventions insufficient. Study design: A 28-year-old patient (BMI = 18.6) with no additional risks for osteoporosis experienced acute lumbosacral pain two months postpartum, while lactating. After conservative therapy, thoracic and lumbar spine were X-rayed: severe pregnancy-associated osteoporosis with vertebral fractures was diagnosed. 2-year treatment with i.v. bisphosphonate ibandronate was initiated (2 mg every 3 months) and calcium and vitamin D supplementation. Results: Rapid improvement was observed. Conclusion: In cases with multiple fractures i.v. bisphosphonate leads to substantial decrease of symptoms and further fractures and significant increase of bone mass density (BMD). Conclusion: In severe cases of pregnancy-associated osteoporosis with multiple fractures i.v. biphosphonate therapy leads to a decrease of symptoms and fracture risk and an increase of bone mass density (BMD).